Ishares Genomic Imm Healthcare Index ETF (XDNA-T) Profile - The Globe and Mail

Name

Fund Family

Underlying Index

Inception Date

Exchange

The iShares Genomics Immunology and Healthcare Index ETF has been designed to provide investors with exposure to the performance of an index, selected at the discretion of BlackRock, that is composed of companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. The current index for the ETF is the NYSE FactSet Global Genomics and Immuno Biopharma Index.

Managed Assets, $K

Shares Outstanding, K

Asset Class

60-Month Beta

Net Asset Value

Expense Ratio

Most Recent Dividend

Last Dividend Date

Annual Dividend Yield (Paid)

Has Options

20-Day Average Volume

52-Week Range29.02-48.48

YTD Return %

1-Year %Chg

3-Year %Chg

5-Year %Chg

More from The Globe

Nuclear ambitions are stirring again, and could turn this stock around

The highest-yielding stocks on the TSX, plus risk data

Outgoing Telus CEO presents sunny view of his tenure, despite stock price challenges

Why this multi-billion-dollar money manager believes emerging markets are poised for outperformance

Small caps to watch: Aecon buys back interest in utilities business, how much Jamieson Wellness could go for in a takeout, and a warning from Sherritt

Thursday’s Insider Report: Multiple executives sell shares in this stock that’s doubled in 2026

Dye & Durham dumps CEO, Tyler Proud now leads company through board committee

Six bargain stock picks from hedge fund managers